Jennifer Smith is the editor of Oncology Practice, part of MDedge Hematology/Oncology. She was previously the editor of Hematology Times, an editor at Principal Investigators Association, and a reporter at The Oneida Daily Dispatch. She has a BS in journalism.
News
Combo shows promise for checkpoint inhibitor-refractory urothelial carcinoma
NATIONAL HARBOR, MD – Combination sitravatinib and nivolumab produced responses in patients with checkpoint...
News
TLR9 agonist may overcome resistance to anti–PD-1 therapy in melanoma
NATIONAL HARBOR, MD. – CMP-001 plus pembrolizumab produced durable responses in patients who had progressed on prior...
News
Smokers with PE have higher rate of hospital readmission
NEW ORLEANS – The rate of readmission within 30 days was significantly higher among PE patients with tobacco...
News
Molecule exhibits activity in heavily pretreated, HER2-positive solid tumors
NATIONAL HARBOR, MD – In a phase 1 trial of 18 evaluable patients, PRS-343, a 4-1BB/HER2 bispecific molecule,...
News
Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression
Atezolizumab provided a 7-month benefit in median overall survival for patients with stage IV non–small cell lung cancer and high PD-L1 expression...
News
Dupilumab effective in early- and late-onset asthma
NEW ORLEANS – Dupilumab may be more effective in reducing severe asthma exacerbations in patients with late-onset asthma.
News
Robotic bronchoscopy beat standard techniques for targeting lung nodules
NEW ORLEANS – Robotic bronchoscopy targeted lung nodules more effectively than did electromagnetic navigation or an ultrathin bronchoscope with...
News
Fluoroscopic system can improve targeting of lung lesions
The system increased the percentage of cases in which the target overlapped with the lesion.
Article
Blood banking experts nab leadership positions at AABB
AABB announces a new president, president-elect, vice president, and secretary.
News
Macitentan produces similar results in PAH-SSc and IPAH/HPAH
NEW ORLEANS – Rates of discontinuation, adverse events, and survival were similar in patients with PAH-SSc and those with IPAH or HPAH.
News
Omalizumab results for asthma varied with fixed airflow obstruction, reversibility
Omalizumab only improved lung function significantly in FAO-negative patients with high reversibility.
News
Macitentan, tadalafil combo found effective for newly diagnosed PAH
Macitentan and tadalafil demonstrated efficacy in a phase 4 trial.
Article
Physician-researcher who promoted industry collaboration dies unexpectedly
Dr. Thomas Peter Stossel died on Sept. 29 at the age of 78. He was best known for his discovery of the cellular proteins filamin and gelsolin.
News
Digital inhaler reveals uncontrolled asthma
NEW ORLEANS – Data from the ProAir Digihaler showed that patients with previous, but not current, exacerbations used their inhalers daily.
News
Study suggests physicians and patients overestimate asthma control
NEW ORLEANS – Physicians and patients overestimated asthma control in an observational study.